Data generated by our AI-based technology has been peer reviewed in several prominent medical journals, including JACC Journals and ESC Journals . Our CEO Andrew Simpson explains.

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nData generated by our AI-based technology has been peer reviewed in several prominent medical journals, including JACC Journals and ESC Journals . Our CEO Andrew Simpson explains.\nOctober 31, 2022\n\nData generated by our AI-based technology has been peer reviewed in several prominent medical journals, including @JACC Journals and @ESC_Journals. What were some of the findings? \n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n